Showing of 3 results
Oxford-Harrington Rare Disease Centre Hosts Virtual Event on Advancing Novel Therapies for Rare Diseases
Researchers discuss successes in their fields; rare disease family advocate shares story
Harrington Discovery Institute Scholar Successfully Moves New Drug for Rare, Genetic Eye Disease into Clinical Trial
Richard Kramer, PhD, hopes to help patients with retinitis pigmentosa.
New therapy seeks to protect from rare muscle-wasting disorder.